![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flag... Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 5.0E-5 | 6.25 | 0.0008 | 0.0009 | 0.0006 | 9954907 | 0.00079014 | CS |
4 | -5.0E-5 | -5.55555555556 | 0.0009 | 0.0011 | 0.0006 | 7787695 | 0.00085595 | CS |
12 | -0.00025 | -22.7272727273 | 0.0011 | 0.0019 | 0.0006 | 9454876 | 0.00103408 | CS |
26 | -0.00185 | -68.5185185185 | 0.0027 | 0.0035 | 0.0006 | 9896676 | 0.00141572 | CS |
52 | -0.01315 | -93.9285714286 | 0.014 | 0.02 | 0.0006 | 11201049 | 0.00340162 | CS |
156 | -0.09115 | -99.0760869565 | 0.092 | 0.132 | 0.0006 | 8707024 | 0.03132781 | CS |
260 | 0.00055 | 183.333333333 | 0.0003 | 0.958 | 0.0001 | 25211136 | 0.06709568 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions